Errors in Table and Abstract

In the Original Investigation titled “Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom,”¹ published January 10, 2022, there were data errors in the columns displaying results for the total cohort and incidence group under the header “Satukijchai et al” in Table 2 and an error in a 95% CI given in the Abstract for the association between transverse myelitis at onset and risk of relapse. This article has been corrected.¹